The Charcot-Marie-Tooth Neuropathy (CMTX3) Complex Structural Variation Causes Differential SOX3 Spatiotemporal Expression.

Overview

1. Northcott Neuroscience Laboratory, ANZAC Research Institute, Sydney Local Health District, Sydney, New South Wales, Australia, anzac.edu.au
2. School of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au
3. Sydney Mass Spectrometry, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au
4. School of Chemistry, Faculty of Science, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au
5. Molecular Medicine Laboratory, Concord Hospital, Sydney, New South Wales, Australia, concordhospital.org
6. Brain and Nerve Research Centre, Concord Clinical School, The University of Sydney, Sydney, New South Wales, Australia, sydney.edu.au

Abstract

Charcot–Marie–Tooth (CMT) neuropathy is a clinically and genetically heterogeneous group of diseases characterized by the length‐dependent axonal degeneration of peripheral nerves. We previously mapped a rare form of X‐linked CMT, CMTX3, to a 5.7‐Mb interval on chromosome Xq26.3‐q27.1 and excluded the coding region of all known genes in the linkage interval for mutations. Whole genome sequencing subsequently identified a 78‐kb region of chromosome 8q24.3 that had been duplicated and inserted into the CMTX3 locus between the genes HAPSTR2 and SOX3. The 78‐kb insertion, which contains a partial transcript of ARHGAP39, fully segregated in families with CMTX3 and was absent in neurologically normal controls. To retain the CMTX3 insertion and investigate its consequences in appropriate neuronal tissue, we generated induced pluripotent stem cells (iPSCs) from CMTX3 fibroblasts. Using bulk RNA sequencing of patient‐derived spinal motor neurons, ARHGAP39 was deemed nonpathogenic by excluding both the formation of novel fusion transcripts and dosage effects from the partial duplication. Subsequent NanoString expression analyses of candidate genes within the CMTX3 locus, across different stages of neuronal differentiation, identified spatiotemporal dysregulation of SOX3. NanoString showed reduced SOX3 expression in patient iPSCs. RNA sequencing detected SOX3 downregulation in CMTX3 neuroepithelial progenitor cells, which was further confirmed by quantitative proteomics. Given the early onset and relatively rapid progression of CMTX3, these data prioritise SOX3 as a leading candidate gene, consistent with its role as one of the earliest transcription factors expressed in the developing nervous system and a key regulator of neuronal fate.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

• uniprot.org/proteomes/up000005640 — at UniProt; found in the text, “2.12. Quantification of SOX3 by Tandem LC‐MS/MS”

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 3, 28 September 2026

• Issue: — → 1

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, pages, dates, 9 authors, 10 MeSH terms, 5 funders, 80 references.

Cite

This paper

Boyling, A., Cutrupi, A. N., Li, D., Crossett, B., Danon, J. J., Harvey-Latham, E. D., Nicholson, G. A., Vucic, S., & Kennerson, M. L. (2026). The Charcot-Marie-Tooth Neuropathy (CMTX3) Complex Structural Variation Causes Differential SOX3 Spatiotemporal Expression. Human mutation, 2026(1), 4225263. https://doi.org/10.1155/humu/4225263

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1210/endrev/bnag008

Diverse SOX3 genetic variants and their associated phenotypic spectrum in human disease.

Journal: Endocrine reviews

In common: genetics / omics, other condition, cellular / molecular, 32 references

[2] doi:10.1186/s13059-026-04126-7

Srr2-dependent SOX2 levels govern the chromatin and transcriptional landscape of adult neural stem cell fate decisions in mouse.

Journal: Genome biology

In common: genetics / omics, 6 references

[3] doi:10.1172/jci.insight.200106

HDAC6 inhibition alleviates mitochondrial trafficking in models of Charcot-Marie-Tooth disease type 2A.

Journal: JCI insight

In common: uniprot.org/proteomes/up000005640, other condition, cellular / molecular, 1 reference

[4] doi:10.1136/bmjopen-2025-110906

Strategic Amyotrophic Lateral Sclerosis Australia-Systems Genomics Consortium (SALSA-SGC): cohort profile.

Journal: BMJ open

In common: other condition, author Steve Vucic

[5] doi:10.1111/bpa.70125

From patient to tumor organoid: Culture protocol choice controls glioblastoma tumor architecture and identity.

Journal: Brain pathology (Zurich, Switzerland)

In common: uniprot.org/proteomes/up000005640, genetics / omics, other condition

[6] doi:10.1186/s12929-026-01253-y

Modeling CLN3 Batten disease in astrocytes reveals alterations in mitochondria homeostasis, fatty acid metabolism and oxidative stress response.

Journal: Journal of biomedical science

In common: uniprot.org/proteomes/up000005640, genetics / omics, cellular / molecular

[7] doi:10.1007/s00262-026-04390-3 [code]

Identification and prioritisation of tumour antigen candidates from 79 glioblastoma transcriptomes.

Journal: Cancer immunology, immunotherapy : CII

In common: genetics / omics, other condition, cellular / molecular, 3 references

[8] doi:10.1038/s43587-026-01207-x [code]

A microprotein atlas of the human frontal cortex in Alzheimer's disease.

Journal: Nature aging

In common: uniprot.org/proteomes/up000005640, genetics / omics

[9] doi:10.1186/s12864-026-12959-6

Cestode infection is linked to transcriptional shifts in neuropeptide signalling and caste-specific ageing pathways in a social insect.

Journal: BMC genomics

In common: other condition, cellular / molecular, 3 references

[10] doi:10.1016/j.nbd.2026.107475

Human TDP-43 expression worsens FTD-related phenotypes in progranulin-insufficient mice.

Journal: Neurobiology of disease

In common: cellular / molecular, 3 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.